Ariose Capital Management Ltd - CHINA BIOLOGIC PRODS INC ownership

CHINA BIOLOGIC PRODS INC's ticker is CBPOXXXX and the CUSIP is 16938C106. A total of 133 filers reported holding CHINA BIOLOGIC PRODS INC in Q1 2016. The put-call ratio across all filers is 0.86 and the average weighting 0.4%.

Quarter-by-quarter ownership
Ariose Capital Management Ltd ownership history of CHINA BIOLOGIC PRODS INC
ValueSharesWeighting
Q4 2016$25,680,000
-7.3%
238,8410.0%8.36%
+10.5%
Q3 2016$27,689,000
+172.8%
238,841
+169.4%
7.56%
-21.0%
Q1 2016$10,149,000
-71.2%
88,655
-64.1%
9.57%
-43.6%
Q4 2015$35,228,000247,28216.97%
Other shareholders
CHINA BIOLOGIC PRODS INC shareholders Q1 2016
NameSharesValueWeighting ↓
WARBURG PINCUS LLC 8,344,200$960,918,0007.67%
RUDMAN ERROL M 130,201$14,994,0005.06%
Ativo Capital Management LLC 59,101$7,258,0002.56%
Kylin Management 188,226$21,676,0002.36%
Monashee Investment Management LLC 40,000$4,606,0002.17%
INSIGHT CAPITAL RESEARCH & MANAGEMENT INC 62,866$7,240,0001.91%
Cormorant Asset Management, LP 111,500$12,840,0001.71%
OBERWEIS ASSET MANAGEMENT INC/ 53,500$6,161,0001.63%
Perceptive Advisors 147,604$16,998,0001.02%
Granite Point Capital Management, L.P. 29,160$3,358,0000.98%
View complete list of CHINA BIOLOGIC PRODS INC shareholders